Top Health Officials Resign After Biden Goes Berserk

Biden and his cabal of COVID tyrants are finally facing some blowback after unleashing authoritarian medical advice to the American people.

Two top Food and Drug Administration officials resigned Tuesday over the Biden administration’s announced plans to roll out COVID-19 booster shots before the agency had approved the inoculations, according to reports.

Dr. Marion Gruber, director of the FDA’s Office of Vaccines Research and Review, and her deputy, Dr. Philip Krause, plan to leave the FDA within the next three months, BioCentury first reported.

The FDA announced the resignations Tuesday.

One former senior FDA leader told Politico that Gruber and Krause were leaving because they felt that the Centers for Disease Control and Prevention had been making vaccine decisions that should have been left to the FDA.

They were also upset with top FDA vaccine official Peter Marks for not insisting that these decisions be made by the agency, Politico said.

The Biden administration announced last month that most people will be offered a COVID-19 booster shot about eight months after vaccination – the final straw for Gruber and Krause, the Politico source said.

Former Trump administration officials are also angry over Biden’s approach to boosters after being criticized for pressuring the agency on drug and vaccine decisions.

More than 11 current and former health officials, said the FDA “is facing a potential mutiny among its staff and outside vaccine advisers, several of whom feel cut out of key decisions and who view the plan to offer boosters to all adults as premature and unnecessary.”

Anonymous sources said there is little coordination between federal health agencies, even as two top FDA officials try to guide the booster rollout.

A senior health official with direct knowledge of the situation reveled that political appointees within the White House largely steered Biden’s booster announcement.

Pfizer completed its initial booster application on Aug. 27, but it was unclear when Moderna and Johnson & Johnson might do likewise.

Author: Asa McCue